Theravance Biopharma, Inc.TBPHNASDAQ
Loading
Income Tax Expense Over TimeExpanding
Percentile Rank100
3Y CAGR+1274.1%
Studio
Year-over-Year Change

Income taxes paid or accrued

3Y CAGR
+1274.1%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
2594.7x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$23.35M+97.8%
2024$11.80M+99.3%
2023$5.92M+65722.2%
2022$9000.00+106.0%
2021$-151000.00+98.2%
2020$-8.52M-63.2%
2019$-5.22M+50.6%
2018$-10.56M-177.1%
2017$13.69M+35.5%
2016$10.11M-